Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study

Although earlier protease inhibitors have been associated with increased risk of cardiovascular disease, whether this increased risk also applies to more contemporary protease inhibitors is unknown. We aimed to assess whether cumulative use of ritonavir-boosted atazanavir and ritonavir-boosted darun...

Ausführliche Beschreibung